AI speeds up design of new antibodies that could target breast cancer

Transparent tumor tomography to visualize the tumor microenvironment showing a mouse model of HER2-positive breast cancer

Visualization of HER2-positive breast cancer in mice

Cultura Creative RF / Alamy Stock Photo

Artificial intelligence has the potential to develop unique antibody treatments for certain types of cancer, suggesting it could accelerate the development of new immunotherapies.

Antibodies are proteins in our body that can bind to other proteins in pathogens and cancer cells. Some neutralize threats directly, while others tag pathogens and cancer cells so that the immune system can locate and attack them.

Some antibodies have turned into drugs used to treat certain types of cancer patients, but for now…

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *